25.35
+0.89
+(3.64%)
At close: January 10 at 4:00:02 PM EST
25.57
+0.22
+(0.87%)
After hours: January 10 at 6:38:07 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,526,154 | 119 |
| Sales | 125,000 | 1 |
| Net Shares Purchased (Sold) | 1,401,154 | 120 |
| Total Insider Shares Held | 1.51M | -- |
| % Net Shares Purchased (Sold) | 1,269.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ROBINSON CHANDLER D Chief Executive Officer | -- | Direct | -- | Dec 31, 2024 |
| CITTADINE ANDREW Chief Operating Officer | -- | Direct | -- | Dec 31, 2024 |
| RADHAKRISHNAN KARTHIK Chief Financial Officer | Purchase at price 16.25 per share. | Direct | 25,188 | Oct 28, 2024 |
| ROBINSON CHANDLER D Chief Executive Officer | -- | Direct | -- | Sep 30, 2024 |
| CITTADINE ANDREW Chief Operating Officer | -- | Direct | -- | Sep 30, 2024 |
| TSUCHIMOTO-EVANS KIM R Chief Financial Officer | -- | Direct | -- | Jun 28, 2024 |
| ROBINSON CHANDLER D Chief Executive Officer | -- | Direct | -- | Jun 28, 2024 |
| CITTADINE ANDREW Chief Operating Officer | -- | Direct | -- | Jun 28, 2024 |
| CITTADINE ANDREW Chief Operating Officer | Purchase at price 0.74 - 0.86 per share. | Direct | 25,574 | Jun 20, 2024 |
| CITTADINE ANDREW Chief Operating Officer | Purchase at price 0.90 - 0.93 per share. | Direct | 32,894 | Jun 17, 2024 |
| CITTADINE ANDREW Chief Operating Officer | Purchase at price 0.76 - 0.78 per share. | Direct | 18,480 | Jun 4, 2024 |
| CITTADINE ANDREW Chief Operating Officer | Purchase at price 0.64 per share. | Direct | 23,051 | May 31, 2024 |
| ROBINSON CHANDLER D Chief Executive Officer | Conversion of Exercise of derivative security at price 0.00 per share. | Direct | 84 | May 28, 2024 |
| TSUCHIMOTO-EVANS KIM R Chief Financial Officer | -- | Direct | -- | Mar 28, 2024 |
| ROBINSON CHANDLER D Chief Executive Officer | -- | Direct | -- | Mar 28, 2024 |
| CITTADINE ANDREW Chief Operating Officer | -- | Direct | -- | Mar 28, 2024 |
| STARR CHRISTOPHER M Director | -- | Direct | -- | Dec 29, 2023 |
| TSUCHIMOTO-EVANS KIM R Chief Financial Officer | -- | Direct | -- | Dec 29, 2023 |
| ANDERSON RAYMOND WILLIAM Director | -- | Direct | -- | Dec 29, 2023 |
| KLAUSNER ARTHUR J Director | -- | Direct | -- | Dec 29, 2023 |
| BROWN MICHAEL J Director | -- | Direct | -- | Dec 29, 2023 |
| ROBINSON CHANDLER D Chief Executive Officer | -- | Direct | -- | Dec 29, 2023 |
| CITTADINE ANDREW Chief Operating Officer | -- | Direct | -- | Dec 29, 2023 |
| STARR CHRISTOPHER M Director | -- | Direct | -- | Sep 29, 2023 |
| TSUCHIMOTO-EVANS KIM R Chief Financial Officer | -- | Direct | -- | Sep 29, 2023 |
| ANDERSON RAYMOND WILLIAM Director | -- | Direct | -- | Sep 29, 2023 |
| KLAUSNER ARTHUR J Director | -- | Direct | -- | Sep 29, 2023 |
| BROWN MICHAEL J Director | -- | Direct | -- | Sep 29, 2023 |
| ROBINSON CHANDLER D Chief Executive Officer | -- | Direct | -- | Sep 29, 2023 |
| CITTADINE ANDREW Chief Operating Officer | -- | Direct | -- | Sep 29, 2023 |
| STARR CHRISTOPHER M Director | -- | Direct | -- | Jun 30, 2023 |
| TSUCHIMOTO-EVANS KIM R Chief Financial Officer | -- | Direct | -- | Jun 30, 2023 |
| ANDERSON RAYMOND WILLIAM Director | -- | Direct | -- | Jun 30, 2023 |
| KLAUSNER ARTHUR J Director | -- | Direct | -- | Jun 30, 2023 |
| BROWN MICHAEL J Director | -- | Direct | -- | Jun 30, 2023 |
| ROBINSON CHANDLER D Chief Executive Officer | -- | Direct | -- | Jun 30, 2023 |
| CITTADINE ANDREW Chief Operating Officer | -- | Direct | -- | Jun 30, 2023 |
| STARR CHRISTOPHER M Director | -- | Direct | -- | Mar 31, 2023 |
| TSUCHIMOTO-EVANS KIM R Chief Financial Officer | -- | Direct | -- | Mar 31, 2023 |
| ANDERSON RAYMOND WILLIAM Director | -- | Direct | -- | Mar 31, 2023 |
| KLAUSNER ARTHUR J Director | -- | Direct | -- | Mar 31, 2023 |
| BROWN MICHAEL J Director | -- | Direct | -- | Mar 31, 2023 |
| ROBINSON CHANDLER D Chief Executive Officer | -- | Direct | -- | Mar 31, 2023 |
| CITTADINE ANDREW Chief Operating Officer | -- | Direct | -- | Mar 31, 2023 |
Related Tickers
KOD Kodiak Sciences Inc.
8.32
-9.57%
ARQT Arcutis Biotherapeutics, Inc.
13.81
-9.56%
DRUG Bright Minds Biosciences Inc.
38.89
-5.24%
LRMR Larimar Therapeutics, Inc.
3.6600
-3.43%
OLMA Olema Pharmaceuticals, Inc.
5.04
-12.35%
TIL Instil Bio, Inc.
19.85
-9.77%
PHGE BiomX Inc.
0.7624
+3.10%
TVGN Tevogen Bio Holdings Inc.
1.4500
+12.40%
NLSP NLS Pharmaceutics AG
2.3200
-3.73%
CADL Candel Therapeutics, Inc.
8.18
-6.30%